$7.77 +0.15 (1.90%) TherapeuticsMD Inc - NYSE Amex Equities

Jul. 27, 2016 | 11:30 AM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 7.77
Trade Time: Jul 27 11:30 AM Eastern Daylight Time
Change: +0.15 (1.90%)
Prev Close: 7.62
Open: 7.65
Bid: 7.76
Ask: 7.76
  1. No results found.
  1. TherapeuticsMD Completes Enrollment in Phase 3 Clinical Trial of Bio-identical Oral Combination of Estradiol and Progesterone Product Candidate

    Benzinga | Oct. 13, 2015 | 07:34AM EST
  2. TherapeuticsMD Completes Enrollment in Phase 3 Clinical Trial of Bio-identical Oral Combination of Estradiol and Progesterone Product Candidate

    Benzinga | Oct. 13, 2015 | 07:00AM EST
  3. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  4. TherapeuticsMD Announces Oral Presentation Of Positive Phase 2 And Bioavailability Data On TX-004HR (VagiCapTM)

    Benzinga | Oct. 15, 2014 | 16:32PM EST
  5. TherapeuticsMD Shares Rally +27% On FBR's Initiation

    Benzinga | Jul. 8, 2014 | 14:49PM EST
  6. Morning Market Movers

    Benzinga | Jul. 8, 2014 | 09:37AM EST
  7. Benzinga's Top Initiations

    Benzinga | Jul. 8, 2014 | 08:26AM EST
  8. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 8, 2014 | 08:04AM EST
  9. FBR Capital Initiates TherapeuticsMD At Outperform, Shares Jump

    Benzinga | Jul. 8, 2014 | 07:34AM EST
  10. UPDATE: TherapeuticsMD Reports Positive Results of Rabbit Irritation Study for Its Estradiol Vaginal Capsule VagiCap™ (TX 004-HR) for Treatment of Vulvar Vaginal Atrophy (VVA)

    Benzinga | Apr. 7, 2014 | 16:09PM EST
  11. BocaGreenMD Launches Prena1 Pearl, Generic Version of vitaMedMD's vitaPearl

    Benzinga | Apr. 7, 2014 | 07:16AM EST
  12. Afternoon Movers for Wednesday, March 19th 2014

    Benzinga | Mar. 19, 2014 | 15:54PM EST
  13. UPDATE: TheraputicsMD Announces Launch of Secondary Offering of 9M Common Shares

    Benzinga | Mar. 18, 2014 | 16:03PM EST
  14. TherapeuticsMD Announces Issuance of U.S. Patent Covering Natural Combination Hormone Replacement Formulations and Therapies, Including TX 12-001-HR

    Benzinga | Jan. 22, 2014 | 16:20PM EST
  15. TherapeuticsMD Receives Notice of Allowance for Patent Covering TX 12-001-HR

    Benzinga | Dec. 9, 2013 | 07:35AM EST
Trading Center